The ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project is addressing the pharmaceutical industry’s desire to deliver medicines more effectively to patients. ADDoPT is developing and implementing advanced digital design techniques that eliminate non-viable drug candidate formulations as early as possible, streamlining design, development and manufacturing processes.
The full launch of the ADDoPT project has been welcomed by a range of stakeholders in the £20.4m government-industry-academia collaboration, which is working across the pharmaceutical value chain to define a system for the top-down,READ MORE
Over 80 researchers and industrialists involved in pharmaceutical development and manufacturing gathered for the Academy of Pharmaceutical Sciences Symposium on the Digital Design of Drug Products on Friday 1st July 2016. Hosted by ADDoPTREAD MORE